A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples